ProfileGDS5822 / ILMN_2762019
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 8% 7% 11% 40% 30% 7% 27% 25% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 19.38
GSM1276600PDAC Late Ablation Control 210.87
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 19.111
GSM1276603PDAC Late Ablation 218.540
GSM1276604PDAC Late Ablation 315.730
GSM1303940PDAC Late Ablation_anti-CTLA4 18.47
GSM1303941PDAC Late Ablation_anti-CTLA4 213.527
GSM1303942PDAC Late Ablation_anti-CTLA4 312.725